Results 91 to 100 of about 1,121 (157)

Pain medication use in patients with X-linked hypophosphatemia treated with burosumab: a retrospective real-world study. [PDF]

JBMR Plus
Macica CM, Li Z, Johnson B, Noman A, Park C, Woods GN.   +5 more
europepmc   +1 more source

Health-related quality of life in French adults with X-linked hypophosphatemia: real-world data from the International XLH Registry. [PDF]

JBMR Plus
Briot K, Lemoine S, Cortet B, Szafors P, Mehsen N, Couture G, Sandilands K, Rylands AJ, Ishii H, Bowden A, Dent JE, Kamenicky P.   +11 more
europepmc   +1 more source

Real-world effectiveness of burosumab across age groups: X-linked hypophosphatemia (XLH) Disease Monitoring Program.

J Clin Endocrinol Metab
Ward LM, Carpenter TO, Cassinelli H, Florenzano P, Imel EA, Khan AA, Johnson B, Yang E, Vincent M, Heerssen HM, Li Z, Simmons JH.   +11 more
europepmc   +1 more source

Burosumab for X-linked hypophosphataemia

, 2021
openaire   +1 more source

Global perspectives on the burden and management of hypophosphataemic osteomalacia in adult patients: an International Osteoporosis Foundation (IOF) survey. [PDF]

Arch Osteoporos
Brandi ML, Halbout P, Pierroz DD, Harvey NC.   +3 more
europepmc   +1 more source

Clinical features of Italian adult individuals with X-linked hypophosphatemia: a multicenter retrospective study. [PDF]

Endocr Connect
Carrara S, Baroncelli GI, Arcidiacono GP, Barale M, Brandi ML, Camozzi V, Castellano E, Cetani F, Comberiati P, Della Valentina S, Eller-Vainicher C, Edvige Foligno N, Giannini S, Gianotti L, Grassi G, Laganà M, Lai S, Marcucci G, Masi L, Paglia F, Palermo A, Perrotta AM, Pigliaru F, Procopio M, Rochira V, Rotondi S, Ruggeri RM, Torres MO, Vai S, Vezzoli G, Zampogna M, Corbetta S.   +31 more
europepmc   +1 more source

Postprandial serum phosphorus and calcium concentrations in adults and children with X-linked hypophosphatemia during burosumab treatment. [PDF]

JBMR Plus
Portale AA, Jan de Beur SM, Munns CF, Peng E, Vincent M, Heerssen HM, Imel EA.   +6 more
europepmc   +1 more source

Preoperative Burosumab With Delayed FGF23 Recovery and High Postoperative Bone Turnover in Tumor-Induced Osteomalacia. [PDF]

JCEM Case Rep
Yeh H, Nge HM, Ghimire A, Gordner C.
europepmc   +1 more source

Patient and carer perceptions and acceptability of current management practices in paediatric X-linked hypophosphatemia treated with burosumab therapy. [PDF]

JBMR Plus
Sandy JL, Rodda CP, Siafarikas A, Biggin A, Wall CL, Collins L, Schindeler A, Simm PJ, Munns CF.   +8 more
europepmc   +1 more source

Case Report: Deep intronic <i>PHEX</i> variant causing aberrant splicing identified by whole genome and targeted RNA sequencing in X-linked hypophosphatemia. [PDF]

Front Endocrinol (Lausanne)
Spranger S, Faust H, Duffek P, Schubert S, Skladny H, Kovacs P, Tönjes A, Popp D.   +7 more
europepmc   +1 more source